Artemisinin resistant falciparum malaria in Myanmar
Artemisinin-based combination therapy (ACT) is first-line treatment for Plasmodium falciparum malaria globally but artemisinin resistance is now prevalent across Southeast Asia. Myanmar has the highest malaria burden in the region, and determining the prevalence of artemisinin resistance and current...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Oxford
2015
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.719870 |